PROMETHEUS BIOSCIENCES, INC. Revenue
PROMETHEUS BIOSCIENCES, INC. reported Revenue of $1.10 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-03-31 was $1.10M, a 71.80% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-12-31 was $653.00K, a 37.03% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $968.00K, a 3.78% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-06-30 was $1.27M, a 289.26% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $6.81M, a 117.61% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $3.13M, a 154.60% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $1.23M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2023-03-31 | $1.10M 10-Q · filed 2023-05-09 | $1.76M derived: sum of 2 quarters · filed 2023-05-09 | $2.73M derived: sum of 3 quarters · filed 2023-05-09 | $4.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.62M derived: sum of 2 quarters · filed 2023-02-28 | $2.89M derived: sum of 3 quarters · filed 2023-02-28 | $6.81M 10-K · filed 2023-02-28 |
| 2022-09-30 | $968.00K 10-Q · filed 2022-11-09 | $2.24M derived: sum of 2 quarters · filed 2022-11-09 | $6.16M 10-Q · filed 2022-11-09 | $7.19M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $1.27M 10-Q · filed 2022-08-11 | $5.19M 10-Q · filed 2022-08-11 | $6.22M derived: sum of 3 quarters · filed 2023-05-09 | $7.23M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $3.92M 10-Q · filed 2023-05-09 | $4.96M derived: sum of 2 quarters · filed 2023-05-09 | $5.96M derived: sum of 3 quarters · filed 2023-05-09 | $6.29M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.04M derived: sum of 2 quarters · filed 2023-02-28 | $2.37M derived: sum of 3 quarters · filed 2023-02-28 | $3.13M 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.01M 10-Q · filed 2022-11-09 | $1.33M derived: sum of 2 quarters · filed 2022-11-09 | $2.09M 10-Q · filed 2022-11-09 | $2.56M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $326.00K 10-Q · filed 2022-08-11 | $1.09M 10-Q · filed 2022-08-11 | $1.55M derived: sum of 3 quarters · filed 2023-02-28 | $1.91M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $760.00K 10-Q · filed 2022-05-12 | $1.22M derived: sum of 2 quarters · filed 2023-02-28 | $1.58M derived: sum of 3 quarters · filed 2023-02-28 | $1.76M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $822.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.00M derived: sum of 3 quarters · filed 2023-02-28 | $1.23M 10-K · filed 2023-02-28 |
| 2020-09-30 | $359.00K 10-Q · filed 2021-11-12 | $538.00K derived: sum of 2 quarters · filed 2021-11-12 | $766.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $179.00K 10-Q · filed 2021-08-11 | $407.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $228.00K 10-Q · filed 2021-05-13 |